The Chilean health authorities approved the use of China’s Sinovac Biotech for children over six years old.
Heriberto García, director of Chile’s Public Health Institute, said that the institution approved the new measure with five votes in favor and one against.
The decision was made after the South American country had fully immunized over three-quarters of its adult population.
Health Minister Enrique Paris said that it is excellent news for school-age children.
“This is great news for school-age children and those that were not included in previous vaccination plans,” Paris said.
The Catholic University of Chile is currently studying the Sinovac effects on 4,000 children aged 3 to 17.
However, according to Garca, the Public Health Institute’s decision was based on a review of information provided by the Sinovac laboratory and information published in medical journals.
The use of the Pfizer-BioNTech vaccine for children over the age of 12 has already been approved in the South American country, with 654,053 children receiving at least one dose since May.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.